Company

ABSCINT

Biotechnology Research Liege, Liège, Be 12 employees

Employees: 12
Contacts: 1
Emails: 1

abscint.com LinkedIn Crunchbase

ABSCINT Overview

Headquarters: Liege, Liège, Be
Website: abscint.com
Industry: Biotechnology Research
Employees: 12
Founded: 2020
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Radiopharmaceuticals Precision imaging Breast cancer Molecular imaging Diagnostics

About ABSCINT

ABSCINT specializes in advanced in vivo imaging diagnostics, focusing on developing innovative PET tracers using single-domain antibodies (sdAbs) for precision targeting. ABSCINT’s primary product is a specific anti-HER2 PET tracer, which enables comprehensive whole-body imaging for evaluating disease heterogeneity in HER2-low and HER2-positive breast cancer. This non-invasive technology offers rapid imaging results within 90 minutes, with minimal radiation exposure. This innovation also opens the door to HER2 reclassification via image-guided biopsies, enhancing diagnostic accuracy, patient care, and monitoring of treatment efficacy. -- ABSCINT, Harnessing Antibody Scintigraphy for Precision Diagnostics in Breast Cancer and Beyond --

ABSCINT Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

ABSCINT Org Chart

Sample employees and titles

Name	Title	Location	Contact
Sara Vandenwijngaert	Junior Partner at Qbic - Venture Capital	Ghent, Flemish Region, Belgium	Email
Karine Clauwaert	Chief Executive Officer at Abscint		View
Leen Limbourg, Md Mba	Venture Capital, Advisor, Chairwoman		View
Stephan Stremersch, Phd	Bd and Cmc Project Manager		View